EBIT: Income before interest and taxes.
Quest Diagnostics Incorporated (DGX) had EBIT of $1.56B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$11.04B |
|
$988.00M |
|
$7.37B |
|
$3.67B |
|
$9.48B |
|
$1.56B |
|
$-238.00M |
|
$1.32B |
|
$1.32B |
|
$1.00B |
|
$1.05B |
|
$1.05B |
|
$1.00B |
|
|
EBIT |
$1.56B |
$2.13B |
|
111.00M |
|
113.00M |
|
$8.87 |
|
$8.75 |
|
| Balance Sheet Financials | |
$2.38B |
|
$2.20B |
|
$13.85B |
|
$16.23B |
|
$2.28B |
|
$5.17B |
|
$6.74B |
|
$9.02B |
|
$7.21B |
|
$-3.38B |
|
$7.21B |
|
110.00M |
|
| Cash Flow Statement Financials | |
$1.89B |
|
$-631.00M |
|
$-1.39B |
|
$549.00M |
|
$420.00M |
|
$-129.00M |
|
$88.00M |
|
$-353.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.04 |
|
-- |
|
-- |
|
0.42 |
|
0.79 |
|
33.21% |
|
14.10% |
|
14.10% |
|
19.27% |
|
11.94% |
|
8.95% |
|
$1.36B |
|
-- |
|
-- |
|
-- |
|
0.68 |
|
38.99 |
|
7.84 |
|
46.57 |
|
14.52% |
|
-30.99% |
|
6.45% |
|
8.45% |
|
$65.51 |
|
$12.03 |
|
$16.69 |
|